Jupiter Pharma

Jupiter Neurosciences is a clinical-stage biotechnology company based in Jupiter, Florida, focused on developing innovative therapies for central nervous system (CNS) disorders and rare diseases. The company's core technology, JOTROL, is a patented oral formulation of resveratrol designed to overcome the compound's natural limitations, such as poor bioavailability and gastrointestinal side effects. By delivering therapeutic levels of resveratrol to the blood and brain, JOTROL aims to treat conditions driven by neuroinflammation and oxidative stress, including Friedreich's Ataxia and Alzheimer's disease. Jupiter Neurosciences is currently advancing its lead candidate through Phase 1 and Phase 2 clinical trials, targeting significant unmet needs in the neurology and orphan drug spaces.